Ron Squarer, CEO at ARRAY BIOPHARMA INC (ARRY), sold 110,000 shares at $21.64 ($2.4M) on 2019-02-07, disclosed to the SEC on 2019-02-08.
Open-market sale of $2.4M ARRY by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ARRY | SELL | 2018-06-29 | $6.6M | — | Filing → |
| ARRY | SELL | 2017-12-19 | $8.9M | — | Filing → |
| ARRY | SELL | 2015-03-04 | $330K | — | Filing → |